Global Drug Discovery Services Market Report Discloses Key Growth Facts, Ongoing R&D, Revenue, Trends and Forecast till 2026
Request Sample Report@ https://www.factmr.com/connectus/sample?flag=S&rep_id=375
According to a study by Fact.MR, the global market for drug discovery services is likely to experience strong growth. By 2026 end, the global market for drug discovery services is also estimated to bring in US$ 16,800.1 million revenue. Advancements in the drug discovery technologies are leading to the better drug discovery services. Some of the upcoming trends in the market in terms of drug discovery technology are regulatory initiatives towards pharmacogenomics technology, combinatorial chemistry technology, etc. there has also been an increase in the adoption of label-free techniques.
Hit-To-Lead Identification to Gain Maximum Traction
Compared to the various processes in the drug discovery services, Hit-To-Lead identification is anticipated to gain maximum traction. Hit-To-Lead identification is likely to exceed US$ 6,900 million revenue towards 2026 end. Increasing research based on the High-Throughput Screening (HTS) is the main factor driving the use of hit-to-lead identification process.
Medicinal Chemistry to be the Largest Type of Drug Discovery Services
Medicinal chemistry is projected to emerge as the largest type in the drug discovery services market. Medicinal chemistry is estimated to bring in close to US$ 6,100 million revenue. There has been an increase in the outsourcing by pharmaceutical companies, this is emerging as the driving factor. Many drug discovery services providers based in Asia are increasing their foothold in North America and Europe.
Small Molecules to Witness Highest Growth in Terms of Revenue
Compared to biologics, small molecules are estimated to account for the highest share in terms of revenue. By 2026 end, small molecules are estimated to exceed US$ 10,800 million revenue. Small molecules are gaining traction as they are easy to characterize, simple and well defined. Also, small molecules can easily enter cells, and can cause cancer cells to die.
Oncology to Hold Largest Revenue Share in the Therapeutic Area
By therapeutic area, oncology is likely to emerge as the largest segment throughout the forecast period. Towards 2026 end, oncology is estimated to exceed US$ 6,900 million revenue. Increasing number of people suffering from cancer is resulting in the high demand for cancer therapies. Hence, oncology is anticipated to experience a significant growth in the coming years.
Browse Full Report with TOC@ https://www.factmr.com/report/375/drug-discovery-services-market
Table of Contents:
1. Global Economic Outlook
2. Global Drug Discovery Services Market - Executive Summary
3. Global Drug Discovery Services Market Overview
3.1.1. Global Drug Discovery Services Market Taxonomy
3.1.2. Global Drug Discovery Services Market Definition
3.2. Global Drug Discovery Services Market Size (US$ Mn) and Forecast, 2012-2026
3.2.1. Global Drug Discovery Services Market Y-o-Y Growth
3.3. Global Drug Discovery Services Market Dynamics
3.4. Supply Chain
3.5. Cost Structure
3.6. PESTL Analysis
3.7. Product Life Cycle Analysis
3.8. Drug Discovery & Development Process
3.9. Roadmap to Optimize Regulatory and Commercial Success
3.10. Evolution of R&D Drug Discovery Outsourcing
3.11. Service Provider List
3.12. Key Participants Market Presence (Intensity Map) By Region
4. Global Drug Discovery Services Market Analysis and Forecast 2012-2026
4.1. Global Drug Discovery Services Market Size and Forecast By Process , 2012-2026
4.1.1. Target Selection Market Size and Forecast, 2012-2026
126.96.36.199. Revenue (US$ Mn) Comparison, By Region
188.8.131.52. Market Share Comparison, By Region
Buy this Report@ https://www.factmr.com/checkout/375/S
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.
11140 Rockville Pike
Rockville, MD 20852
Follow Us on Linkedin: https://www.linkedin.com/company/factmr/
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Drug Discovery Services Market Report Discloses Key Growth Facts, Ongoing R&D, Revenue, Trends and Forecast till 2026 here
News-ID: 1085693 • Views: 141
More Releases from Fact.MR
Ergonomic Designs of Furniture and a Favourable Policy Framework for Newer Entra …
The global office furniture market is expected to create ~ US$ 22 Billion worth of incremental opportunity over the forecast period. Since the last two decades, the number of small, micro, and medium-sized enterprises has increased drastically in developed and developing countries. Moreover, constant provision from private investments and governments is fueling the growth of the private sector, which is further propelling the office furniture market growth to a great
Cyclopentane Market Statistics Based on Upcoming Chemical Industry Trends and Su …
The adoption of cyclopentane in commercial refrigerators has opened up new opportunities for the global cyclopentane market. Cyclopentane is popularly used as a foam blowing agent for polyurethane foams that are used to insulate freezers and refrigerators. The commercial refrigerator sector is experiencing a healthy growth across the globe, with Asia pacific region as the fastest growing region. The importance of commercial refrigerators is also increasing due to fluctuating climatic
Advanced Technologies in Blow Molded Containers Market Will Offer Lucrative Grow …
The global food & beverage industry accounts for the lion’s share in the blow molded containers market. The industry has shown fast pace growth in the recent years owing to rise in population and increase in per capita consumer spending, thereby driving expansion in the blow molded containers market. Concerning revenue, the global blow molded containers market is projected to expand at a CAGR of ~ 6% during the forecast
Squeezable Plastic Tubes Show Maximum Penetration in the Beauty and Personal Car …
Global sales of the squeezable plastic tubes in 2018 surpassed US$ 700 Mn and are anticipated to expand at a moderate pace over the forecast period, according to a recently published Fact.MR study. Europe will maintain its supremacy in the market for the squeezable plastic tubes, owing to the widespread consumption in various end-use applications of squeezable plastic tubes. Emerging markets like India, China, North Middle East & Africa, etc.
More Releases for Drug
Biologics Drug Discovery Market
2019-2025 Biologics Drug Discovery Market Report with Depth Analysis The biologics drug discovery involves target identification, hit-to-lead stage, lead identification and optimization. The report presents a comprehensive overview, market size, shares, and growth opportunities of Biologics Drug Discovery market by product type, application, key manufacturers and key regions. Request For Free report Sample -https://www.reportsmonitor.com/request_sample/306320 Scope of the Report: Furthermore, Biologics Drug Discovery Market report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers or
Opioid Antagonist Drug Market
The global market has been prognosticated to earn demand from popular types of products such as external use, oral and applications such as household and hospital. The Company has made available another publication in its Healthcare archive of market intelligence reports, which is titled “Global Opioid Antagonist Drug Market Research Report 2018.” While the threat of substitutes and technological risks could have an unfavorable impact on the global market, potential
Drug and cosmetics
Drug and Cosmetics Conferences regards each one of the individuals to go to the On “Drug and Cosmetics” amidst October 17-October 18, 2018 in Toronto, Canada which melds brief keynote presentations, speaker talks, Exhibition, Symposia, Workshops. Drug and Cosmetics Congress is one of the meetings and conferences which will be visited by all the prestigious cosmetologists, Scientists, fiery inspectors, postgraduates, affiliations, business meanders under a solitary rooftop. DRug and cosmetics BLESSY MATHEW Program
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: email@example.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: firstname.lastname@example.org or +91-11-47067990 Report Table of Contents 1. Indispensable Advent of Microcapsules 1.1 Trajectory of Microencapsulation 1.2 Why and wherefores for Microencapsulation 2. Characterization of Microcapsules 2.1 Composition of Microcapsules 2.2 Parameters Influencing Microcapsules 3. Engineering Technology of Microcapsules 3.1 Physical Manufacturing Technologies 3.2 Physicochemical and Chemical Technologies 4. Applicability of Microcapsules 4.1 Microcapsules in Pharmaceuticals 4.2 Microcapsules in Nutraceuticals
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning